Similarly, our analysis of the TCGA EC cohort demonstrates that POLE-mutant and MSI tumors are characterized by a significantly higher number of mutations predicted to result in major histocompatibility complex-binding neoantigens, and a correspondingly higher number of tumor-infiltrating CD8+ T cells, as assessed by CD8A mRNA levels. This evidence concerns the gene POLE and neoplasm.